ATE414766T1 - Nukleinsäuresequenzen zur potenzierung der expression eines nützlichen gens und dessen verfahren - Google Patents

Nukleinsäuresequenzen zur potenzierung der expression eines nützlichen gens und dessen verfahren

Info

Publication number
ATE414766T1
ATE414766T1 AT99929745T AT99929745T ATE414766T1 AT E414766 T1 ATE414766 T1 AT E414766T1 AT 99929745 T AT99929745 T AT 99929745T AT 99929745 T AT99929745 T AT 99929745T AT E414766 T1 ATE414766 T1 AT E414766T1
Authority
AT
Austria
Prior art keywords
expression
gene
nucleic acid
acid sequences
ires
Prior art date
Application number
AT99929745T
Other languages
English (en)
Inventor
Osamu Yamada
Hiroshi Yoshida
Jing Zhang
Original Assignee
Fuso Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Ind filed Critical Fuso Pharmaceutical Ind
Application granted granted Critical
Publication of ATE414766T1 publication Critical patent/ATE414766T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99929745T 1998-08-27 1999-07-08 Nukleinsäuresequenzen zur potenzierung der expression eines nützlichen gens und dessen verfahren ATE414766T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24136798 1998-08-27

Publications (1)

Publication Number Publication Date
ATE414766T1 true ATE414766T1 (de) 2008-12-15

Family

ID=17073245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99929745T ATE414766T1 (de) 1998-08-27 1999-07-08 Nukleinsäuresequenzen zur potenzierung der expression eines nützlichen gens und dessen verfahren

Country Status (10)

Country Link
US (1) US6869779B1 (de)
EP (1) EP1108780B1 (de)
JP (1) JP4390392B2 (de)
KR (1) KR100516045B1 (de)
CN (2) CN1272433C (de)
AT (1) ATE414766T1 (de)
AU (1) AU770116B2 (de)
CA (1) CA2341050C (de)
DE (1) DE69939938D1 (de)
WO (1) WO2000012691A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115197965A (zh) * 2015-06-10 2022-10-18 霍欧奇帕生物科技有限公司 Hpv疫苗
IT201700105372A1 (it) * 2017-09-20 2019-03-20 Fondazione St Italiano Tecnologia Molecola di acido nucleico funzionale e relativo uso
KR20230028375A (ko) * 2020-06-25 2023-02-28 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 원형 rna 번역을 구동하는 유전 요소와 이를 사용하는 방법
CN114480496B (zh) * 2022-02-23 2024-05-07 新乡医学院 一种昆虫细胞用双荧光素酶报告基因载体、构建方法、重组载体及应用
WO2025140249A1 (en) * 2023-12-26 2025-07-03 Suzhou Abogen Biosciences Co., Ltd. A circular rna and relevant constructs and a method using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0769899A (ja) 1993-09-02 1995-03-14 Mitsubishi Chem Corp 抗ウイルス剤
AU4208897A (en) 1996-09-16 1998-04-02 Merck Patent Gmbh Oligocistronic expression system for the production of heteromeric proteins
JP3926887B2 (ja) 1997-05-26 2007-06-06 財団法人化学及血清療法研究所 多分子発現カセット及びその利用

Also Published As

Publication number Publication date
US6869779B1 (en) 2005-03-22
JP4390392B2 (ja) 2009-12-24
AU770116B2 (en) 2004-02-12
CN100554428C (zh) 2009-10-28
KR100516045B1 (ko) 2005-09-26
CN1324401A (zh) 2001-11-28
DE69939938D1 (de) 2009-01-02
KR20010085682A (ko) 2001-09-07
CA2341050C (en) 2009-04-21
CA2341050A1 (en) 2000-03-09
CN1272433C (zh) 2006-08-30
EP1108780B1 (de) 2008-11-19
EP1108780A1 (de) 2001-06-20
CN1827768A (zh) 2006-09-06
WO2000012691A1 (fr) 2000-03-09
AU4649899A (en) 2000-03-21
EP1108780A4 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
Neumann et al. RNA polymerase I-mediated expression of influenza viral RNA molecules
Fodor et al. The influenza virus panhandle is involved in the initiation of transcription
GB2349885A (en) Characterisation of gene function using double stranded RNA inhibition
DE69834908D1 (de) Verfahren zur erhöhung der expression von endogenen oder exogenen genprodukten in pflanzen
DE60035885D1 (de) Paramyxoviren, die eine modifizierte transkriptionsstartsequenz umfassen
DE69943389D1 (de) Verfahren und mittel zum erhalt von veränderten phänotypen
ATE550430T1 (de) Aus bakterien der gattung corynebacterium stammende promoternukleinsäure , den promoter umfassende expressionskassette , den vektor umfassende wirtszelle sowie verfahren zur expression eines gens unter verwendung der zelle .
JP2018530336A5 (de)
CN114634930A (zh) 使用rna指导型内切核酸酶改善基因组工程特异性的组合物和方法
DE59813372D1 (de) Rekombinanter vektor, der infektiöse virale genomsequenzen mit einer grösse von mehr als 100 kb enthält, verfahren zu seiner herstellung und verwendung
WO2003080807A8 (en) Compositions and methods for suppressing eukaryotic gene expression
EP0804609A4 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
DE69301554D1 (de) Dendritisches makromolecül und verfahren zu seiner herstellung
ATE335086T1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
DE69939938D1 (de) Nukleinsäuresequenzen zur potenzierung der expression eines nützlichen gens und dessen verfahren
CA2285221A1 (en) Improvements relating to the specificity of gene expression
Mayeda et al. Short donor site sequences inserted within the intron of β-globin pre-mRNA serve for splicing in vitro
DE69943215D1 (de) Verfahren zum retten der rna-viren
Hayano et al. Coding strategy of rice stripe virus: major nonstructural protein is encoded in viral RNA segment 4 and coat protein in RNA complementary to segment 3
DE69637041D1 (de) Dna-fragment, dieses enthaltender rekombinanter vektor und verfahren zur expression von fremdgenen unter dessen verwendung
ATE504648T1 (de) Rna-interferenz für das gen znfn3a1 als verfahren zur hemmung des wachstums von krebszellen
Ma et al. Identification of tumor metastasisrelated gene TMSG-1 by mRNA differential display
WO2000003013A3 (en) Gene and protein involved in liver regeneration
WO2022187278A1 (en) Nucleic acid detection and analysis systems
FR2701960B1 (fr) Polyribozyme apte à conférer, aux plantes, une résistance aux virus et plantes résistantes produisant ce polyribozyme.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties